Clinical Trial Update: A Pilot Study on the Safety and Efficacy of YOLT-204 for Transfusion-Dependent Beta-Thalassemia [EARLY_Phase 1]

View source ↗

Summary

A pilot Phase 1 trial evaluating the safety and preliminary efficacy of YOLT-204 in transfusion-dependent beta-thalassemia; the study status is not yet recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia

Drugs mentioned

• YOLT-204

Snippet

Sponsor: First Affiliated Hospital of Guangxi Medical University | Conditions: Transfusion Dependent Beta Thalassemia | EARLY_Phase 1 | Status: NOT_YET_RECRUITING